CPCLIN

CPClin (Centro de Pesquisas Clínicas) is a leading Brazilian clinical research center and contract research organization (CRO) that is part of Dasa, the largest diagnostic medicine company in Latin America. Established in 2003 and headquartered in São Paulo, the center specializes in conducting Phase I through IV clinical trials across a wide range of therapeutic areas, including cardiology, endocrinology, neurology, and rare diseases. CPClin has participated in over 300 studies, including the landmark international multicenter trial for tirzepatide (Mounjaro). The center is recognized for its innovative use of artificial intelligence and generative AI chatbots to streamline patient recruitment and engagement. With a 700 m² dedicated facility and a multidisciplinary team of specialists, CPClin serves as a key partner for global pharmaceutical companies like Eli Lilly, Amgen, and Roche in the Latin American market.